-+*The Ontario HIV Epidemiology and Surveillance Initiative (OHESI) is pleased to announce the release of a new report titled “HIV Testing in Ontario, 2019”. It describes the trends in HIV testing in Ontario over the past decade (2010-2019), with a focus on HIV tests in 2019, broken down down by type of test (nominal, coded, […]
OHESI report: HIV testing in Ontario, 2019 Read More »
-+*Download pdf Questions What are the predictors of methamphetamine use among men who have sex with men? Key take-home messages An abundance of literature details problematic sexualized drug use among men who have sex with men (1–3); additionally, several interventions attempt to address methamphetamine dependence in this population (4, 5). Several factors are associated with
Factors associated with methamphetamine use among men who have sex with men Read More »
-+*Download pdf Question What is the effectiveness of and what are the best practices for using contingency management and incentives for health care issues such as HIV, STIs, and PrEP? Key take-home messages Using contingency management and incentives at the different steps of HIV care continuum (such as testing, treatment adherence, viral suppressions) is widely
-+*Download pdf Questions What is the effectiveness of and what are the best practices for using contingency management and incentives to support linkage to care and treatment for hepatitis C infection among people who use drugs? Key take-home messages Recent studies in Canada have indicated that hepatitis C virus (HCV) treatment uptake among individuals who
-+*Anti-Black racism is a deeply rooted systemic issue that permeates all aspects of Canadian society. It manifests in a myriad of ways that are acutely relevant to our work in the HIV sector, including barriers to accessing services, disparities in physical and mental health outcomes, poorer social determinants of health, and the disproportionate impact of
Confronting Anti-Black Racism and the Disproportionate Impact of HIV on Black Canadians Read More »
-+*Are you HIV positive and concerned about the COVID-19 vaccine? Are you concerned about your health but reluctant or afraid to reach out for heath care? The OHTN is pleased to share this factsheet for people living with HIV. It answers a number of questions theymay have about their care and well-being during the COVID-19
-+*We are excited to share a factsheet on the impacts of COVID-19: “We Never Closed: AIDS Service Organizations during the COVID-19 pandemic”. This factsheet is based on the results of a COVID-19 ASO Impact Evaluation Survey, completed by Ontario ASOs in December 2020 and January 2021.
Ontario AIDS Service Organizations during the COVID-19 pandemic Read More »
-+*The OHTN is pleased to share another opportunity at HQ, Toronto’s forthcoming centre for excellence in gay men’s health. Currently under construction at 790 Bay, HQ Toronto will provide tailored mental health services, sexual health services, and community/social programming. It will provide an accessible, safe, welcoming space for all cis men and trans people who
Opportunity @ HQ Toronto: Director, Community Engagement, Social Programs and Inclusion Read More »
-+*We have put together a brief summary of the most up-to-date evidence on COVID-19 vaccines and their safety and effectiveness in people living with HIV. We will be updating this presentation as more information becomes available and more evidence emerges. Updated April 28, 2021. Download pdf
-+*Download pdf Question What are the benefits of universal antiretroviral therapy (ART) coverage on individual and population level health outcomes? Key take-home messages As of 2017, the annual cost of single-tablet antiretrovirals (ART) in Ontario was estimated to be CAD 15,552 according to the Ontario Drug Benefit Formulary (1, 2). Universal, no-cost ART for all
Impact of universal coverage for antiretroviral therapy (ART) on health outcomes Read More »
